Adaptimmune Therapeutics: Q1 Earnings Insights

Adaptimmune Therapeutics ADAP reported its Q1 earnings results on Monday, May 9, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Adaptimmune Therapeutics beat estimated earnings by 77.27%, reporting an EPS of $-0.05 versus an estimate of $-0.22.

Revenue was up $3.14 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 4.95% drop in the share price the next day.

Here's a look at Adaptimmune Therapeutics's past performance:

To track all earnings releases for Adaptimmune Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.